Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

6.8K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
6.8K
Lipid Catabolism01:25

Lipid Catabolism

1.4K
Triglycerides serve as crucial long-term energy storage molecules in microorganisms, providing a dense source of metabolic energy. Their breakdown is mediated by lipases, which hydrolyze triglycerides into glycerol and free fatty acids. Each of these components follows distinct metabolic pathways, ultimately contributing to ATP synthesis and cellular energy homeostasis.Glycerol MetabolismGlycerol, released from triglyceride hydrolysis, is phosphorylated by glycerol kinase to form...
1.4K
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

113
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
113
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

317
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
317
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

835
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
835
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

1.7K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical Characteristics of Cerebral Venous Sinus Thrombosis in Patients with Systemic Lupus Erythematosus: A Single-Centre Experience in China.

Journal of immunology research·2015
Same author

[Clinical characteristics of 15 cases of microscopic polyangiitis associated with alveolar hemorrhage].

Zhonghua nei ke za zhi·2015
Same author

Identification of low Ca(2+) stress-induced embryo apoptosis response genes in Arachis hypogaea by SSH-associated library lift (SSHaLL).

Plant biotechnology journal·2015
Same author

A simple score for predicting renal artery stenosis in patients with ischemic heart disease.

International journal of clinical and experimental medicine·2015
Same author

HLA-DPB1 variant rs3117242 is associated with anti-neutrophil cytoplasmic antibody-associated vasculitides in a Han Chinese population.

International journal of rheumatic diseases·2015
Same author

Identification of jasmonic acid-associated microRNAs and characterization of the regulatory roles of the miR319/TCP4 module under root-knot nematode stress in tomato.

Journal of experimental botany·2015
Same journal

Cardiovascular disease and miRNA.

Advances in clinical chemistry·2026
Same journal

RNA biomarkers in antidoping.

Advances in clinical chemistry·2026
Same journal

Biomarkers for assessing magnesium status.

Advances in clinical chemistry·2026
Same journal

Advances in microfluidic extracellular vesicle technology.

Advances in clinical chemistry·2026
Same journal

Chronic low-grade inflammation in vegetarians and vegans: Biomarker evidence and methodological considerations.

Advances in clinical chemistry·2026
Same journal

Biomarkers in heart failure.

Advances in clinical chemistry·2026
See all related articles

Related Experiment Video

Updated: Apr 21, 2026

The MPLEx Protocol for Multi-omic Analyses of Soil Samples
10:12

The MPLEx Protocol for Multi-omic Analyses of Soil Samples

Published on: May 30, 2018

10.4K

Metabolomics in dyslipidemia.

Hua Chen, Hua Miao, Ya-Long Feng

    Advances in Clinical Chemistry
    |October 28, 2014
    PubMed
    Summary
    This summary is machine-generated.

    Metabolomics offers a novel approach to identify sensitive biomarkers for hyperlipidemia, enabling earlier diagnosis and improved treatment. This review explores metabolomic techniques and their application in understanding hyperlipidemia mechanisms.

    More Related Videos

    Assessing Whole-Body Lipid-Handling Capacity in Mice
    07:57

    Assessing Whole-Body Lipid-Handling Capacity in Mice

    Published on: November 24, 2020

    3.7K
    Extraction of Aqueous Metabolites from Cultured Adherent Cells for Metabolomic Analysis by Capillary Electrophoresis-Mass Spectrometry
    11:39

    Extraction of Aqueous Metabolites from Cultured Adherent Cells for Metabolomic Analysis by Capillary Electrophoresis-Mass Spectrometry

    Published on: June 9, 2019

    9.5K

    Related Experiment Videos

    Last Updated: Apr 21, 2026

    The MPLEx Protocol for Multi-omic Analyses of Soil Samples
    10:12

    The MPLEx Protocol for Multi-omic Analyses of Soil Samples

    Published on: May 30, 2018

    10.4K
    Assessing Whole-Body Lipid-Handling Capacity in Mice
    07:57

    Assessing Whole-Body Lipid-Handling Capacity in Mice

    Published on: November 24, 2020

    3.7K
    Extraction of Aqueous Metabolites from Cultured Adherent Cells for Metabolomic Analysis by Capillary Electrophoresis-Mass Spectrometry
    11:39

    Extraction of Aqueous Metabolites from Cultured Adherent Cells for Metabolomic Analysis by Capillary Electrophoresis-Mass Spectrometry

    Published on: June 9, 2019

    9.5K

    Area of Science:

    • Biochemistry
    • Metabolomics
    • Cardiovascular Disease Research

    Background:

    • Hyperlipidemia poses a significant global health challenge, with current biomarkers lacking early diagnostic sensitivity.
    • Existing clinical markers for hyperlipidemia (triglyceride, total cholesterol, LDL, HDL) often show changes only in advanced stages of the disease.

    Purpose of the Study:

    • To review the application of metabolomics in identifying novel, sensitive biomarkers for early hyperlipidemia detection.
    • To explore the potential of metabolomics for understanding the pathophysiologic mechanisms of hyperlipidemia.
    • To summarize analytical techniques, data handling, and findings from metabolomic studies in hyperlipidemia.

    Main Methods:

    • Review of analytical techniques in untargeted metabolomics.
    • Analysis of data collection and processing strategies for metabolomic studies.
    • Synthesis of findings from metabolomics research in hyperlipidemia animal models and human clinical studies.

    Main Results:

    • Metabolomics provides a comprehensive metabolic profile, offering potential for improved diagnostic accuracy in hyperlipidemia.
    • This approach can reveal underlying pathophysiologic mechanisms of hyperlipidemia beyond traditional markers.
    • The review covers hypolipemia mechanisms and discusses antilipemic drug therapies.

    Conclusions:

    • Metabolomics presents a promising avenue for discovering sensitive biomarkers for early hyperlipidemia diagnosis and management.
    • This holistic approach enhances understanding of hyperlipidemia's complex metabolic underpinnings.
    • Further research integrating metabolomic insights can advance clinical practice for hyperlipidemia treatment.